Back to results
US 2023/0406923 A1Published application
Methods for determining and achieving therapeutically effective doses of anti-cd47 agents in treatment of cancer
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsIrving L. Weissman, Mark P. Chao, Ravindra Majeti, Jie Liu, Jens-Peter Volkmer
Life of this patent
Estimating the term…
Abstract
Methods are provided for treating a subject with an anti-CD47 agent.
Claims8
1-21. (canceled)
A pharmaceutical aqueous formulation comprising an effective dose of Hu5F9-G4 antibody;
- and pharmaceutically acceptable excipients comprising 10 mM sodium Acetate, 5% (w/v) sorbitol, 0.01% (w/v) polysorbate 20, pH 5.0.
Dependencies are inferred from the claim text.